title: Protective effects of thymoquinone against cholestatic oxidative stress and hepatic damage after biliary obstruction in rats.
abstract: The aim of this study was to examine the preventive and therapeutic effects of thymoquinone (TQ) against cholestatic oxidative stress and liver damage in common bile duct ligated rats. A total of 24 male Sprague-Dawley rats were divided into three groups: control, bile duct ligation (BDL) and BDL + received TQ; each group contain 8 animals. The rats in TQ treated groups were given TQ (50 mg/kg body weight) once a day orally for 2 weeks starting 3 days prior to BDL operation. To date, no more biochemical and histopathological changes on common bile duct ligated rats by TQ treatment have been reported. The application of BDL clearly increased the tissue hydroxyproline (HP) content, malondialdehyde (MDA) levels and decreased the antioxidant enzyme [superoxide dismutase (SOD), glutathione peroxidase (GPx)] activities. TQ treatment significantly decreased the elevated tissue HP content, and MDA levels and raised the reduced of SOD, and GPx enzymes in the tissues. The changes demonstrating the bile duct proliferation and fibrosis in expanded portal tracts include the extension of proliferated bile ducts into lobules, mononuclear cells, and neutrophil infiltration into the widened portal areas were observed in BDL group. Treatment of BDL with TQ attenuated alterations in liver histology. The immunopositivity of alpha smooth muscle actin and proliferating cell nuclear antigen in BDL were observed to be reduced with the TQ treatment. The present study demonstrates that oral administration of TQ in bile duct ligated rats maintained antioxidant defenses and reduces liver oxidative damage and ductular proliferation. This effect of TQ may be useful in the preservation of liver function in cholestasis.
authors.affiliation: Department of General Surgery, Faculty of Medicine, Trakya University, 22030, Edirne, Turkey.
authors.forename: Serhat
authors.initials: S
authors.lastname: Oguz
authors.forename: Mehmet
authors.initials: M
authors.lastname: Kanter
authors.forename: Mustafa
authors.initials: M
authors.lastname: Erboga
authors.forename: Cengiz
authors.initials: C
authors.lastname: Erenoglu
mesh_terms: D000199:Actins / Q000096:biosynthesis; D000284:Administration, Oral; D000818:Animals; D034961:Antigens, Nuclear / Q000096:biosynthesis; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D016227:Benzoquinones / Q000008:administration & dosage / Q000627:therapeutic use*; D001651:Cholestasis, Extrahepatic / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D003135:Common Bile Duct / Q000473:pathology / Q000601:surgery; D005979:Glutathione Peroxidase / Q000378:metabolism; D006909:Hydroxyproline / Q000378:metabolism; D008026:Ligation; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D051381:Rats; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D000199:Actins; D034961:Antigens, Nuclear; D000975:Antioxidants; D016227:Benzoquinones; D008315:Malondialdehyde; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; C003466:thymoquinone; D006909:Hydroxyproline